Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants

Completed · Not applicable

Conditions studied: Gestational Diabetes

In brief

The purpose of this study is to determine whether a 14 week intervention is successful in improving outcomes for women with gestational diabetes mellitus and their infants.

Key facts

Study ID

NCT01809431

Run by

University of North Carolina, Chapel Hill

People needed

200

Starts

2012-05-01

Expected to finish

2014-07-01

Last updated by the study team

2024-06-13

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women between 22-36 weeks of pregnancy who are diagnosed with GDM
• A diagnosis of GDM during the current pregnancy by two or more 100g Oral Glucose Tolerance Test (OGTT) values exceeding established thresholds (fasting 95, 1h 180, 2h 155, 3h 140 mg/dL)
• Age 18-45 years old
• A pre-pregnancy body mass index > 25kg/m2
• Ability to read and write in English
• Willingness to consent for themselves and their infant

You may not qualify if…

• They have a A1c ≥ 6.5 mg/dL (Type 2 diabetes)

Where it is running

• UNC-Rex Health Care — Raleigh, North Carolina, United States
• WakeMed — Raleigh, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.